The 2015 annual meeting of the American Society for Clinical Oncology, themed “Illumination and innovation: transforming data into learning,” brought together more than 37,000 attendees in Chicago and featured numerous clinical advances that will improve the lives of our cancer patients. That said, to a first-timer, the gathering probably would have felt like an update on using the immune system to fight cancer, despite our more than 30 years of using such strategies. The science behind the development of these promising monoclonal antibodies is outstanding, and the impact will certainly be far reaching.
Click on the PDF icon at the top of this introduction to read the full article.